Liquiritin apioside

Name: Liquiritin apioside
Brand: MedChemExpress
SKU: HY-N1471
Rating: 4.5 (1 reviews)

Cat. No.: HY-N1471 Purity: 99.60%: Data Sheet
SDS

COA
Handling Instructions Technical Support

Solubility

In Vivo Dissolution Calculator

Liquiritin apioside is an orally active inhibitor of TRPV1 receptor. Liquiritin apioside selectively inhibits laryngeal chemoreflex (LCR) and has no significant effect on mechanoreflex (LMR). Liquiritin apioside inhibits LCR by inhibiting reactive oxygen species (ROS) and NADPH oxidase, weakening the interaction between ROS and TRPV1. Liquiritin apioside can be used in the research of respiratory-related diseases.

For research use only. We do not sell to patients.

Liquiritin apioside Chemical Structure

CAS No. : 74639-14-8

Size	Stock	Quantity
5 mg	In-stock	Estimated Time of Arrival: December 31
10 mg	In-stock	Estimated Time of Arrival: December 31
25 mg	In-stock	Estimated Time of Arrival: December 31
50 mg	Get quote
100 mg	Get quote

or Bulk Inquiry

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Other Forms of Liquiritin apioside:

Liquiritin apioside (Standard) Get quote

1 Publications Citing Use of MCE Liquiritin apioside

•J Ethnopharmacol. 17 June 2022, 115451.

Featured Recommendations

•Related Screening Libraries:

Biological Activity
Purity & Documentation
References
Customer Review

Description

In Vitro

Superior laryngeal nerve (SLN) related electrophysiological experiments: Liquiritin apioside (0.1 mM; overnight) can significantly change the electrophysiological kinetics of laryngeal C neuron currents induced by 1.5 μM Capsaicin (HY-10448P)，reducing the current amplitude, increasing the rise time and prolonging the decay time^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay^[1]

Cell Line:	Laryngeal C-neurons (isolated from nodose/jugular ganglia of rat pups)
Concentration:	0.1 mM
Incubation Time:	Overnight; with 1.5 μM Capsaicin
Result:	Inhibited the CAP-induced currents in laryngeal C-neurons. Reduced the current amplitudes, increased the rise times, and prolonged the decay times. Of the eighteen laryngeal C-neurons tested, three neurons (16%) were not CAP-responsive.

In Vivo

Liquiritin apioside (10 μg/μL, intralaryngeal or perineural administration; single dose; 10 min, 20 min) significantly attenuates the apnea, hypertension, and bradycardia responses to the laryngeal chemoreflex (LCR) induced by Capsaicin (HY-10448)，hydrochloric acid (HCl)，and distilled water (DW) in rat pups, but has no significant effect on the laryngeal mechanoreflex (LMR) induced by air pulse (AP) ^[1].
Liquiritin apioside (0.01 g/kg, 0.2 g/kg; po; once daily for 10 days) ameliorates DSS-induced colitis in mice, and modulates the gut microbial diversity and composition^[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:	Laryngeal reflexe study in Sprague-Dawley rat (250-350 g) pups^[1]
Dosage:	10 μg/μL (diluted in saline)
Administration:	Intralaryngeal perfusion for 10 minutes or peri-treatment for 20 minutes, single dose
Result:	Significantly reduced the apneic responses to CAP, HCl, and DW, as well as attenuated the hypertension and bradycardia responses to these stimuli. Did not change the cardiorespiratory responses to AP. Peri-SLN treatment with Liquiritin apioside also suppressed the apnea, hypertension, and bradycardia responses to CAP, HCl, and DW, similar to the effect of intralaryngeal treatment.

Animal Model:	DSS-induced colitis model in C57BL/6 mice (male, 18–22 g, 8–10 weeks)^[2]
Dosage:	0.01 g/kg, 0.02 g/kg (diluted in saline)
Administration:	Oral gavaged for 10 days, once daily
Result:	Exhibited the same pathological changes as that of the ABX (DSS) group mice, specifically, comparable weight loss, DAI score, colon length, and histology score.

Molecular Weight

550.51

Formula

C₂₆H₃₀O₁₃

CAS No.

74639-14-8

Appearance

Solid

Color

White to light yellow

SMILES

O[C@H]([C@H]1O[C@]2([H])OC[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](CO)O[C@H]1OC(C=C3)=CC=C3[C@@H]4CC(C5=CC=C(O)C=C5O4)=O

Structure Classification

Initial Source

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

4°C, protect from light

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

Solvent & Solubility

In Vitro:

DMSO : 100 mg/mL (181.65 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions

Concentration Solvent Mass	1 mg	5 mg	10 mg

1 mM	1.8165 mL	9.0825 mL	18.1650 mL
5 mM	0.3633 mL	1.8165 mL	3.6330 mL
10 mM	0.1816 mL	0.9082 mL	1.8165 mL

View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Molarity Calculator
Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

This equation is commonly abbreviated as: C₁V₁ = C₂V₂

Concentration _(start)

Volume _(start)

Concentration _(final)

Volume _(final)

In Vivo:

Select the appropriate dissolution method based on your experimental animal and administration route.

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

Protocol 1

Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (4.54 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Protocol 2

Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.5 mg/mL (4.54 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Protocol 3

Add each solvent one by one: 10% DMSO 90% Corn Oil
Solubility: ≥ 2.5 mg/mL (4.54 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown). If the continuous dosing period exceeds half a month, please choose this protocol carefully.
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL Corn oil, and mix evenly.

In Vivo Dissolution Calculator

Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Please enter your animal formula composition:

DMSO +

Tween-80 +

Saline

Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.

The co-solvents required include: DMSO, PEG300/PEG400, Tween 80. All of co-solvents are available by MedChemExpress (MCE).

Purity & Documentation

Purity: 99.60%

Select Batch:

Data Sheet (279 KB) SDS (252 KB)

COA (251 KB) HNMR (295 KB) LCMS (97 KB)

Handling Instructions (2659 KB)

References

[1]. Wei W, et al. Liquiritin apioside attenuates laryngeal chemoreflex but not mechanoreflex in rat pups. Am J Physiol Lung Cell Mol Physiol. 2020 Jan 1;318 (1) :L89-L97. [Content Brief]

[2]. Xia X, et al. Liquiritin apioside alleviates colonic inflammation and accompanying depression-like symptoms in colitis by gut metabolites and the balance of Th17/Treg. Phytomedicine. 2023 Nov;120:155039. [Content Brief]

Complete Stock Solution Preparation Table

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg

DMSO	1 mM	1.8165 mL	9.0825 mL	18.1650 mL	45.4124 mL
	5 mM	0.3633 mL	1.8165 mL	3.6330 mL	9.0825 mL
	10 mM	0.1816 mL	0.9082 mL	1.8165 mL	4.5412 mL
	15 mM	0.1211 mL	0.6055 mL	1.2110 mL	3.0275 mL
	20 mM	0.0908 mL	0.4541 mL	0.9082 mL	2.2706 mL
	25 mM	0.0727 mL	0.3633 mL	0.7266 mL	1.8165 mL
	30 mM	0.0605 mL	0.3027 mL	0.6055 mL	1.5137 mL
	40 mM	0.0454 mL	0.2271 mL	0.4541 mL	1.1353 mL
	50 mM	0.0363 mL	0.1816 mL	0.3633 mL	0.9082 mL
	60 mM	0.0303 mL	0.1514 mL	0.3027 mL	0.7569 mL
	80 mM	0.0227 mL	0.1135 mL	0.2271 mL	0.5677 mL
	100 mM	0.0182 mL	0.0908 mL	0.1816 mL	0.4541 mL